clinical trial · NCT06916897
A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers
Healthy SubjectssevasemtenVerapamil
brief summary
The purposes of this Phase 1 study of sevasemten are to: 1. Evaluate the effect of multiple-dose administration of verapamil on the single-dose of sevasemten in healthy adults 2. Evaluate the safety and tolerability of a single dose of sevasemten administered with and without verapamil in healthy adult subjects. 3. Evaluate the safety and tolerability of a single dose of sevasemten administered with and without food in healthy adult subjects.
started
Jan 8, 2025
primary completion
Feb 22, 2025
completion
Feb 22, 2025
last updated
Apr 8, 2025
official title
A Phase 1, Open-Label Study to Evaluate the Effect of Verapamil and Food on the Pharmacokinetics of Sevasemten in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol